Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.700
+0.040 (2.41%)
At close: Jun 6, 2025, 4:00 PM
1.670
-0.030 (-1.76%)
After-hours: Jun 6, 2025, 4:00 PM EDT

Apyx Medical Statistics

Total Valuation

Apyx Medical has a market cap or net worth of $63.12 million. The enterprise value is $71.02 million.

Market Cap 63.12M
Enterprise Value 71.02M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date May 8, 2025
Ex-Dividend Date n/a

Share Statistics

Apyx Medical has 37.79 million shares outstanding. The number of shares has increased by 7.02% in one year.

Current Share Class 37.79M
Shares Outstanding 37.79M
Shares Change (YoY) +7.02%
Shares Change (QoQ) +6.58%
Owned by Insiders (%) 14.56%
Owned by Institutions (%) 24.46%
Float 25.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 1.31
Forward PS 1.27
PB Ratio 6.00
P/TBV Ratio 6.00
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 1.50
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.45, with a Debt / Equity ratio of 3.66.

Current Ratio 5.45
Quick Ratio 4.49
Debt / Equity 3.66
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -2.60

Financial Efficiency

Return on equity (ROE) is -129.51% and return on invested capital (ROIC) is -17.58%.

Return on Equity (ROE) -129.51%
Return on Assets (ROA) -14.60%
Return on Invested Capital (ROIC) -17.58%
Return on Capital Employed (ROCE) -30.17%
Revenue Per Employee $214,945
Profits Per Employee -$91,077
Employee Count 220
Asset Turnover 0.72
Inventory Turnover 2.08

Taxes

In the past 12 months, Apyx Medical has paid $248,000 in taxes.

Income Tax 248,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +6.25% in the last 52 weeks. The beta is 1.20, so Apyx Medical's price volatility has been higher than the market average.

Beta (5Y) 1.20
52-Week Price Change +6.25%
50-Day Moving Average 1.25
200-Day Moving Average 1.33
Relative Strength Index (RSI) 61.18
Average Volume (20 Days) 464,587

Short Selling Information

The latest short interest is 413,602, so 1.09% of the outstanding shares have been sold short.

Short Interest 413,602
Short Previous Month 258,778
Short % of Shares Out 1.09%
Short % of Float 1.61%
Short Ratio (days to cover) 0.98

Income Statement

In the last 12 months, Apyx Medical had revenue of $47.29 million and -$20.04 million in losses. Loss per share was -$0.54.

Revenue 47.29M
Gross Profit 29.08M
Operating Income -15.28M
Pretax Income -28.50M
Net Income -20.04M
EBITDA -14.70M
EBIT -15.28M
Loss Per Share -$0.54
Full Income Statement

Balance Sheet

The company has $31.01 million in cash and $38.92 million in debt, giving a net cash position of -$7.91 million or -$0.21 per share.

Cash & Cash Equivalents 31.01M
Total Debt 38.92M
Net Cash -7.91M
Net Cash Per Share -$0.21
Equity (Book Value) 10.64M
Book Value Per Share 0.28
Working Capital 42.34M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$12.41 million and capital expenditures -$742,000, giving a free cash flow of -$13.15 million.

Operating Cash Flow -12.41M
Capital Expenditures -742,000
Free Cash Flow -13.15M
FCF Per Share -$0.35
Full Cash Flow Statement

Margins

Gross margin is 61.49%, with operating and profit margins of -32.31% and -42.37%.

Gross Margin 61.49%
Operating Margin -32.31%
Pretax Margin -42.07%
Profit Margin -42.37%
EBITDA Margin -31.09%
EBIT Margin -32.31%
FCF Margin n/a

Dividends & Yields

Apyx Medical does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.02%
Shareholder Yield -7.02%
Earnings Yield -31.75%
FCF Yield -20.83%

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Hold
Analyst Count 2
Revenue Growth Forecast (5Y) 41.47%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

The last stock split was on January 6, 1994. It was a reverse split with a ratio of 0.06666:1.

Last Split Date Jan 6, 1994
Split Type Reverse
Split Ratio 0.06666:1

Scores

Apyx Medical has an Altman Z-Score of -0.52 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.52
Piotroski F-Score 1